Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07729891

Real-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery: a Study for the Early Identification of Complications in the Surgical Ward Following Surgery in Patients Not Eligible for Intensive Care Admission.

This study aims to evaluate whether continuous vital sign monitoring with wearable devices can help detect postoperative complications in surgical ward earlier than standard hospital monitoring. In particular, the goal of this observational study is to evaluate if the wireless wearable devices Portrait Mobile (GE Healthcare) can detect early signs of complications after major urologic surgery in adults who are not eligible for intensive care unit admission. The main questions it aims to answer are:

* Can continuous monitoring of vital signs (heart rate, breathing rate, blood oxygen) detect health problems earlier than standard nurse checks in the urology ward? * How many times do participants' vital signs change in ways that suggest a complication is developing during the first days after surgery? * Does the vital sign trend and/or the deviation from patients' baseline suggest a complication is developing during the first days after surgery? * Does continuous monitoring help healthcare providers intervene before patients become critically ill thus reducing complications burden or severity and reducing unplanned intensive care admission? Participants in the intervention cohort will wear a wireless patch-like device on their chest that continuously tracks their heart rate, breathing rate, and blood oxygen levels. The device sends this information to hospital staff through a secure wireless connection while participants recover in the regular urology ward after surgery. Participants in the intervention cohort will wear the device for 3 days after surgery or until they leave the hospital. Healthcare providers will receive alerts if vital signs change in ways that suggest a complication may be developing. This may help providers treat problems earlier and prevent patients from becoming critically ill. All participants will also receive standard post-surgical care, including regular nurse checks of vital signs.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

2^ Anestesia, Rianimazione, Terapia Intensiva - Azienda Ospedaliero Universitaria di Parma

Parma, 43126, Italy

Location status: Recruiting

Location contact

Matteo Panizzi

CONTACT

[email protected]

+393494156020

Matteo Panizzi

SUB_INVESTIGATOR

Valentina Bellini

CONTACT

[email protected]

+393388284629

Valentina Bellini

PRINCIPAL_INVESTIGATOR

About this study

The RECOVER study evaluates the use of continuous wearable monitoring in surgical ward for the early detection of postoperative complications in patients recovering after major surgery. The study begins with the evaluation of urologic surgery. It focuses on whether continuous measurement of vital signs in the surgical ward can identify clinical deterioration and postoperative complications earlier than routine postoperative surveillance alone: postoperative complications are often preceded by changes in vital signs and may develop during the first days after surgery, when patients are usually monitored intermittently in the ward. Continuous wireless monitoring is intended to provide earlier recognition of respiratory and hemodynamic deterioration while patients recover outside the operating room and outside intensive care.

The main objective is to assess whether continuous monitoring of vital signs can detect early signs of medical or surgical postoperative complications after moderate-to-high complexity urologic surgery performed under general anesthesia. The protocol is particularly focused on identifying episodes of desaturation, tachypnea, hemodynamic instability, and persistent deviation of vital signs from patient's baseline values during the postoperative period.

Patient enrollment takes place in the Urology ward before the scheduled operation. During the preoperative anesthesiology evaluation, the anesthesiologist provides study information and asks the patient to participate by signing informed consent and personal data processing forms. This enrollment process is maintained in both patient pathways described in the protocol.

For patients managed with continuous monitoring, the wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery, and the device does not replace standard postoperative monitoring.

The wearable platform used in the protocol is the Portrait Mobile® system by GE HealthCare. It continuously records respiratory rate, oxygen saturation, and heart rate, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Data are transmitted through the hospital Wi-Fi network to a dedicated monitoring infrastructure, where alarms can be visualized on the ward monitoring station.

Alarm thresholds are predefined by the investigator using values derived from the National Early Warning System Score. These thresholds include respiratory rate below 11 or above 21 breaths per minute, oxygen saturation below 95%, and heart rate below 50 or above 91 beats per minute. In addition to threshold-based events, the protocol evaluates persistent deviation from baseline, defined as a change greater than 20% for at least 24 hours, in order to capture clinically meaningful trends rather than isolated abnormal values.

When an alarm is generated, ward nursing staff are asked to determine whether the alert is appropriate or represents a false positive. They also record whether the patient is at rest or moving at the time of the alert, allowing the investigators to assess device performance under real clinical conditions. Subsequent clinical actions, including review by the ward physician, on-call physician activation, or request for anesthesiology consultation, are reconstructed from nursing handover and the clinical chart.

For patients managed with usual postoperative surveillance alone, enrollment still occurs during the preoperative anesthesiology assessment and clinical data are collected after informed consent is obtained. These patients receive standard ward monitoring without wearable continuous monitoring, and their postoperative course is documented for comparison of clinical events and outcomes.

The primary endpoints are the number of desaturation events, tachypnea events, and hemodynamic instability events. Secondary endpoints include false positive rate, number of physician alerts, number of requests for intensive care consultation, unplanned intensive care admission directly from the operating area, transfer to intensive care during postoperative ward stay, postoperative complications, re-surgery, correlation between parameter trends and outcomes, hospital length of stay, barriers to rehabilitation, patient satisfaction, and integration of the system with the hospital IT infrastructure.

All complications will be recorded in the case report form and graded according to the Clavien-Dindo classification. Collected data include baseline patient characteristics, average preoperative vital sign values, diagnosis, type of surgery, intraoperative data, continuous monitoring data, postoperative clinical course, pain, functional recovery, total hospital stay, ICU stay, and patient satisfaction with the monitoring system.

The system is not expected to expose patients to additional risk and does not interfere with the usual diagnostic and therapeutic pathway. Wireless wearable monitoring should not negatively affect mobilization, rehabilitation, or functional recovery, which is relevant because preservation of postoperative recovery is one of the practical concerns addressed by the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ability to give informed consent and consent to the processing of personal data by signing the relevant forms;
  • Aged over 18 years old
  • Medium-to-high complexity urological surgery without the need for post-operative monitoring in the Intensive Care Unit
  • Surgery performed under general anaesthesia
  • Discharge to the ward is scheduled upon leaving the operating theatre

Exclusion criteria

  • Refusal or inability to consent to participation
  • Patients under 18 years old
  • Planned admission to Post-Operative Intensive Care Unit after the surgery
  • Unplanned admission to the Post-Operative Intensive Care Unit at the end of the surgery
  • Anaesthetic technique other than general anaesthesia.

Treatment and study plan

Continuous vital sign monitoring with Portrait Mobile in surgical ward

Device

The wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery. Respiratory rate, oxygen saturation, and heart rate are continuously collected, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Alarm thresholds are predefined by the investigator using values derived from NEWS and alarms calibrated over baseline parameters.

Primary outcomes

  1. Number of event of desaturation

    Time frame: 72 hours after the surgery

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate <11 and >21 breaths/min; SpO₂ <95%; Heart rate <50 bpm and >91 bpm)

  2. Number of event of tachypnoea or bradypnoea

    Time frame: 72 hours after the surgery

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate <11 and >21 breaths/min; SpO₂ <95%; Heart rate <50 bpm and >91 bpm)

  3. Number of event of haemodinamic instability

    Time frame: 72 hours after the surgery

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate <11 and >21 breaths/min; SpO₂ <95%; Heart rate <50 bpm and >91 bpm)

Secondary outcomes

  1. False-positive rate

    Time frame: 72 hours after the surgery

    Number of alarms triggered without a real Event

  2. Number of on-call doctor call-outs

    Time frame: 72 hours after the surgery

    Nurse activation of the medical staff of the surgery ward

  3. Number of requests for Anesthesia consultation

    Time frame: 72 hours after surgery

    Activation of Hospital medical emergency team

  4. Unscheduled direct admission to the Intensive Care Unit from the operating theatre and unplanned transfer to the Intensive Care Unit during the post-operative period (from the surgical ward)

    Time frame: 72 hours after surgery

    After Anesthesiological evaluation and activation of Hospital medical emergency team

  5. Occurrence of post-surgical complications (any type) or reoperation

    Time frame: 72 hours after surgery or patients discharge

    Any type of complication and their severity (Clavien Dindo score) that occur during the intervention period

  6. Correlation between parameters trend, including persistent deviation from pre-operative values, and patient outcome or length of hospital stay.

    Time frame: Untill patient discharge from hospital

    To investigate the incidence of complication and/or prolonged LOS if the patient experience a progressive postoperative deviation from baseline vital parameters.

  7. Barriers to patient rehabilitation and patients satisfaction

    Time frame: 72 hours after surgery or discharge

    Investigate whether the wearable device hinders patient rehabilitation, expressed as the percentage of patients reporting a reduced capacity for postoperative early mobilization or rehabilitation, and patients global satisfaction through a questionnaire.

Study contacts

Contact information is provided by the study sponsor or research team.

Matteo Panizzi

CONTACT

[email protected]

+393494156020

Valentina Bellini

CONTACT

[email protected]

+393388284629

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliero-Universitaria di Parma

Other

Registry information

Official study title

Real-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery

Acronym: RECOVER

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 28, 2026
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.